Idarucizumab more effectively reverses the anticoagulant effects of dabigatran acylglucuronide than dabigatran
Abstract Dabigatran acylglucuronide, an active metabolite of dabigatran, exhibits higher plasma concentrations and distinct anticoagulant effects compared to dabigatran, suggesting that it may play a more significant role in overall anticoagulant activity than previously assumed. Idarucizumab, a mon...
Saved in:
| Main Authors: | Jong-Min Kim, Young Yoon Bang, Kyoung-Ah Kim, Jin-Woo Park, Ji-Young Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-08417-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans
by: Jin-Woo Park, et al.
Published: (2025-01-01) -
IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE
by: Olga O. Shakhmatova
Published: (2018-12-01) -
Practical use of idarucizumab
by: G. R. Ramazanov, et al.
Published: (2023-11-01) -
Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
by: E. I. Baranova, et al.
Published: (2019-11-01) -
Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01)